VIPS:NYSEVipshop Holdings Limited Analysis
Data as of 2026-03-14 - not real-time
$16.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Vipshop (VIPS) trades at $16, below its 20‑day SMA of $16.80 and 50‑day SMA of $17.30, signaling a bearish short‑term bias. The RSI sits at 40.6, indicating the stock is not yet oversold, while the MACD histogram remains negative, reinforcing bearish momentum. Despite this, volume is increasing, suggesting accumulating interest. Volatility is elevated at nearly 39% over the past 30 days, and beta of 0.72 points to modest market sensitivity. Fundamentals show a low trailing PE of 7.8 and forward PE of 5.8, coupled with a dividend yield of 3.9% and a payout ratio under 25%, implying sustainable income. Recent earnings beat expectations (EPS $0.81 vs $0.78) even as revenue slipped 2.3% YoY, highlighting resilient profitability.
Analyst consensus remains positive with a “Buy” rating and a median target of $19.84, implying roughly 25% upside from current levels. The company holds $28.8 bn in cash against $6.4 bn of debt, providing a strong balance sheet to weather cyclical pressures. Gross margins of 23% and ROE of 17% indicate decent operational efficiency, while the dividend and cash generation support shareholder returns. However, exposure to China’s consumer sector introduces medium regulatory and high geographic risk. Overall, the stock appears undervalued relative to peers, offering a blend of value and modest growth characteristics.
Analyst consensus remains positive with a “Buy” rating and a median target of $19.84, implying roughly 25% upside from current levels. The company holds $28.8 bn in cash against $6.4 bn of debt, providing a strong balance sheet to weather cyclical pressures. Gross margins of 23% and ROE of 17% indicate decent operational efficiency, while the dividend and cash generation support shareholder returns. However, exposure to China’s consumer sector introduces medium regulatory and high geographic risk. Overall, the stock appears undervalued relative to peers, offering a blend of value and modest growth characteristics.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- earnings beat with EPS surprise
- increasing volume indicating accumulation
- support level near $15.39
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- valuation gap with low PE and forward PE
- ~25% upside to analyst target
- sustainable dividend yield
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- strong cash position offsets cyclical exposure
- regulatory and geographic headwinds in China
- steady dividend supports long‑term income
Key Metrics & Analysis
Financial Health
Revenue Growth-2.30%
Profit Margin6.84%
P/E Ratio7.8
ROE17.23%
ROA6.61%
Debt/Equity14.51
P/B Ratio1.3
Technical Analysis
TrendBearish
RSI40.6
Support$15.39
Resistance$18.60
MA 20$16.80
MA 50$17.30
MA 200$17.39
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
Target Price$20.10
Upside/Downside25.60%
GradeUndervalued
TypeBlend
Dividend Yield3.88%
Risk Assessment
Beta0.72
Volatility38.94%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.